These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8809206)

  • 21. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
    Krieg M; Bartsch W; Janssen W; Voigt KD
    J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
    [No Abstract]   [Full Text] [Related]  

  • 22. Testosterone metabolism by homogenates of human prostates with benign hyperplasia: effects of zinc, cadmium and other bivalent cations.
    Sinquin G; Morfin RF; Charles JF; Floch HH
    J Steroid Biochem; 1984 Mar; 20(3):773-80. PubMed ID: 6200704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
    Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (De)phosphorylation agents influence 5 alpha-reduction of testosterone in human prostate.
    Le Goff JM; Martin PM; Raynaud JP
    Endocrinology; 1988 Sep; 123(3):1693-5. PubMed ID: 2456919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective interactions between prostate fibroblast and epithelial cells in co-culture maintain the BPH phenotype.
    Bayne CW; Ross M; Donnelly F; Chapman K; Buck C; Bollina P; Habib FK
    Urol Int; 1998 Oct; 61(1):1-7. PubMed ID: 9792974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen metabolism in the human prostatic cancer cell line LNCaP.
    Negri-Cesi P; Motta M
    J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):89-96. PubMed ID: 7947355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tamoxifen on the binding and metabolism of testosterone by human prostatic tissue and plasma in vitro.
    Habib FK; Rafati G; Robinson MR; Stitch SR
    J Endocrinol; 1979 Dec; 83(3):369-78. PubMed ID: 94084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
    Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
    J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
    [No Abstract]   [Full Text] [Related]  

  • 31. Testosterone metabolism by homogenates of human prostates with benign hyperplasia: effect of tissular concentrations of zinc, magnesium and copper.
    Sinquin G; Morfin R; Charles JF; Floch HH
    J Steroid Biochem; 1982 Oct; 17(4):395-400. PubMed ID: 6182394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen metabolism and actions in rat ventral prostate epithelial and stromal cell cultures.
    Orlowski J; Clark AF
    Biochem Cell Biol; 1986 Jun; 64(6):583-93. PubMed ID: 3741675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen metabolism in cultured prostatic cells.
    Ofner P; Terracio L; Vena RL
    Prog Clin Biol Res; 1984; 145():363-80. PubMed ID: 6201883
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential regulation of steroidogenic enzymes metabolizing testosterone or dihydrotestosterone by human chorionic gonadotropin in cultured rat neonatal interstitial cells.
    Murono EP
    Acta Endocrinol (Copenh); 1990 Mar; 122(3):289-95. PubMed ID: 2158194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen metabolism in different target tissues.
    Martini L; Celotti F; Lechuga MJ; Melcangi RC; Motta M; Negri-Cesi P; Poletti A; Zoppi S
    Ann N Y Acad Sci; 1990; 595():184-98. PubMed ID: 1695827
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
    Bard DR; Lasnitzki I
    J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
    Smith CM; Ballard SA; Wyllie MG; Masters JR
    J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone metabolism of fibroblasts grown from prostatic carcinoma, benign prostatic hyperplasia and skin fibroblasts.
    Schweikert HU; Hein HJ; Romijn JC; Schröder FH
    J Urol; 1982 Feb; 127(2):361-7. PubMed ID: 6174738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland.
    Leake A; Chisholm GD; Habib FK
    J Steroid Biochem; 1984 Feb; 20(2):651-5. PubMed ID: 6200703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.